UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial

The American journal of gastroenterology, 2017-03, Vol.112 (3), p.441-446

2017

Volltextzugriff (PDF)

Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo‐controlled HARMONIZE‐Global study

ESC Heart Failure, 2020-02, Vol.7 (1), p.54-64

2020

Volltextzugriff (PDF)

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial

JAMA : the journal of the American Medical Association, 2011-05, Vol.305 (19), p.1969

2011

Volltextzugriff (PDF)

Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial

The American journal of gastroenterology, 2017-03, Vol.112 (3), p.441-446

2017

Volltextzugriff (PDF)

Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-Term Esomeprazole Therapy

Clinical gastroenterology and hepatology, 2016-05, Vol.14 (5), p.678-685.e3

2016

Volltextzugriff (PDF)

Effect of baseline characteristics on response to proton pump inhibitors in patients with peptic ulcer bleeding

Journal of digestive diseases, 2017-02, Vol.18 (2), p.99-106

2017

Volltextzugriff (PDF)

Enteric-coated budesonide for the induction and maintenance of remission of Crohn's disease in children

Current medical research and opinion, 2017-07, Vol.33 (7), p.1261-1268

2017

Volltextzugriff (PDF)

Esophageal Stricture: Incidence, Treatment Patterns, and Recurrence Rate

The American journal of gastroenterology, 2006-12, Vol.101 (12), p.2685-2692

2006

Volltextzugriff (PDF)

Sa1139 High-Dose Intravenous Proton Pump Inhibitors for Prevention of Recurrent Peptic Ulcer Bleeding in Chinese and Western Populations: Rebleeding Is Not Influenced by Ethnicity

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-210-S-210

2014

Volltextzugriff (PDF)

Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease

BMC gastroenterology, 2016-04, Vol.16 (48), p.48-48, Article 48

2016

Volltextzugriff (PDF)

Standardization of Surgical Technique in Antireflux Surgery: The LOTUS Trial Experience

World journal of surgery, 2008-06, Vol.32 (6), p.995-998

2008

Volltextzugriff (PDF)

Long-term effect on symptoms and quality of life of maintenance therapy with esomeprazole 20 mg daily: a post hoc analysis of the LOTUS trial

Current medical research and opinion, 2015-01, Vol.31 (1), p.65-73

2015

Volltextzugriff (PDF)

Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients

Advances in therapy, 2015-11, Vol.32 (11), p.1160-1176

2015

Volltextzugriff (PDF)

Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers

Scandinavian journal of gastroenterology, 2010-09, Vol.45 (9), p.1048-1058

2010

Volltextzugriff (PDF)

Inter-Observer Agreement On Assessment of Photo Documentation in Bleeding Peptic Ulcer

Gastrointestinal endoscopy, 2009-04, Vol.69 (5), p.AB186-AB186

2009

Volltextzugriff (PDF)

High Density Eosinophilic Infiltration in Gastro-Esophageal Reflux Disease is Rare and Probably Not Related to Primary Eosinophilic Esophagitis; A Cohort Study From the LOTUS trial

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-187-S-187

2011

Volltextzugriff (PDF)

Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients

European journal of gastroenterology & hepatology, 2008-06, Vol.20 (6), p.526-536

2008

Volltextzugriff (PDF)

284 Laparoscopic Antireflux Surgery vs Long-Term Esomeprazole Treatment for Chronic GERD. Final Results After 5 Yrs of Follow up in the Lotus Study

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-53-S-53

2010

Volltextzugriff (PDF)

Factors that influence heartburn relapse in patients with reflux esophagitis

Journal of clinical gastroenterology, 2006-09, Vol.40 (Supplement 4), p.S200

2006

Volltextzugriff (PDF)

Factors that influence resolution of heartburn in patients with reflux esophagitis

Journal of clinical gastroenterology, 2006-09, Vol.40 (Supplement 4), p.S199-S200

2006

Volltextzugriff (PDF)

356: Rebleeding Risk for Oozing Peptic Ulcer Bleeding (PUB) in a Large International Study—A Reassessment Based Upon a Multivariate Analysis

Gastrointestinal endoscopy, 2010-04, Vol.71 (5), p.AB117-AB117

2010

Volltextzugriff (PDF)

Is There a Subgroup of Patients with Forrest IB (Oozing) Peptic Ulcer Bleeding At Increased Risk of Re-Bleeding?

Gastrointestinal endoscopy, 2009-04, Vol.69 (5), p.AB118-AB118

2009

Volltextzugriff (PDF)

339 The 3-Year Outcome of Optimal Medical or Surgical Management of GERD Patients with Barrett's Esophagus: the Lotus Trial Experience

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-845-A-845

2008

Volltextzugriff (PDF)

Esomeprazole therapy and esophageal histology in endoscopy-negative reflux disease (ENRD) — the CHEER study

Gastroenterology (New York, N.Y. 1943), 2003-04, Vol.124 (4), p.A416-A416

2003

Volltextzugriff (PDF)

Are endoscopy negative GERD and reflux esophagitis different diseases? Baseline histology in GERD patients off-therapy — the CHEER study

Gastroenterology (New York, N.Y. 1943), 2003-04, Vol.124 (4), p.A416-A416

2003

Volltextzugriff (PDF)

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(138)

Publikationsform

Sprache

Englisch
(164)
Schwedisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial

Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo‐controlled HARMONIZE‐Global study

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial

Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial

Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-Term Esomeprazole Therapy

Effect of baseline characteristics on response to proton pump inhibitors in patients with peptic ulcer bleeding

Enteric-coated budesonide for the induction and maintenance of remission of Crohn's disease in children

Esophageal Stricture: Incidence, Treatment Patterns, and Recurrence Rate

Sa1139 High-Dose Intravenous Proton Pump Inhibitors for Prevention of Recurrent Peptic Ulcer Bleeding in Chinese and Western Populations: Rebleeding Is Not Influenced by Ethnicity

Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease

Standardization of Surgical Technique in Antireflux Surgery: The LOTUS Trial Experience

Long-term effect on symptoms and quality of life of maintenance therapy with esomeprazole 20 mg daily: a post hoc analysis of the LOTUS trial

Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients

Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers

Inter-Observer Agreement On Assessment of Photo Documentation in Bleeding Peptic Ulcer

High Density Eosinophilic Infiltration in Gastro-Esophageal Reflux Disease is Rare and Probably Not Related to Primary Eosinophilic Esophagitis; A Cohort Study From the LOTUS trial

Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients

284 Laparoscopic Antireflux Surgery vs Long-Term Esomeprazole Treatment for Chronic GERD. Final Results After 5 Yrs of Follow up in the Lotus Study

Factors that influence heartburn relapse in patients with reflux esophagitis

Factors that influence resolution of heartburn in patients with reflux esophagitis

356: Rebleeding Risk for Oozing Peptic Ulcer Bleeding (PUB) in a Large International Study—A Reassessment Based Upon a Multivariate Analysis

Is There a Subgroup of Patients with Forrest IB (Oozing) Peptic Ulcer Bleeding At Increased Risk of Re-Bleeding?

339 The 3-Year Outcome of Optimal Medical or Surgical Management of GERD Patients with Barrett's Esophagus: the Lotus Trial Experience

Esomeprazole therapy and esophageal histology in endoscopy-negative reflux disease (ENRD) — the CHEER study

Are endoscopy negative GERD and reflux esophagitis different diseases? Baseline histology in GERD patients off-therapy — the CHEER study

Suchergebnisse filtern